Individuals Stopping Anti-Obesity Jabs Regain Pounds Four Times Faster Compared to Those on Conventional Diets

A recent study suggests that people who stop using new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who stop traditional diet and exercise programs.

Published data in a leading health publication points out that while obese individuals can lose substantial amounts of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"Users using these medications must be aware of the danger of quick weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb.

This pace of regain means a return to original mass within about one and a half years.

Comparing Approaches

The study, which looked at dozens of studies involving thousands of patients, compared the effects of the injectable medications with conventional dieting.

Researchers emphasize that individuals who shed pounds through lifestyle changes alone typically experience a more gradual weight regain—approximately 100 grams monthly—post-intervention.

Explaining the Quick Regain

Experts believe the way of the drugs accounts for the accelerated weight return.

These medications imitate a natural hormone called GLP-1, which helps regulate hunger.

"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication means hunger is uncontrolled, making overeating a significant risk."

A Lifelong Issue?

Medical guidelines advise the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.

Professionals contend that, given the high risk of relapse, the treatment should be considered ongoing.

This perspective is supported by drug manufacturers, who note that the findings "underscore the persistent nature of obesity," akin to managing diseases like high blood pressure.

User Accounts

Individuals who have come off the medication report a powerful return of hunger.

"I experienced a trigger flipping and I was suddenly ravenous," described an individual.

The struggle is compounded if individuals have not developed lasting lifestyle or habit changes during treatment.

Widespread Adoption

Recent estimates indicate that a significant number of adults in the UK have used these injections in the last 12 months, with interest continuing to grow.

• Use is greater among women than men.
• The middle-aged age group shows the greatest usage rates.
• Many access the drugs through private prescriptions rather than public health services.

Ultimately, experts stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing lifestyle support.